Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study

PURPOSE: The aim of the present study was to assess the efficacy and safety of transarterial chemoembolization (TACE) combined with atezolizumab and bevacizumab (hereafter, TACE-Atez/Bev) in the treatment of advanced hepatocellular carcinoma (HCC) patients. MATERIALS AND METHODS: Clinical informatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Fei, Shi, Changsheng, Zhang, Guofu, Luo, Jun, Zheng, Jiaping, Hao, Weiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506240/
https://www.ncbi.nlm.nih.gov/pubmed/37718456
http://dx.doi.org/10.1186/s12885-023-11389-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506240/
https://www.ncbi.nlm.nih.gov/pubmed/37718456
http://dx.doi.org/10.1186/s12885-023-11389-x

Ejemplares similares